Alzheimer’s disease News
Latest articles and news about Alzheimer’s disease on AXL Media.
Latest Articles
- Mayo Clinic Study Identifies Critical Age Thresholds for Accelerated Alzheimer’s Biomarker and Cognitive Decline
Published: May 1, 2026
Section: Health Technology
A new study published in Alzheimer’s and Dementia has pinpointed specific age breakpoints, primarily between 62 and 72 years, when biological markers of Alzheimer's disease begin t...
- Experimental Drug P7C3-A20 Restores Memory in Mice With Advanced Alzheimer’s by Rebooting Vital Brain Energy Molecule
Published: Apr 30, 2026
Section: Research
Researchers at Case Western Reserve University have successfully reversed cognitive decline in animal models of late-stage Alzheimer’s disease using a drug that restores NAD+ energ...
- USC Study Identifies Three Unique Cognitive Decline Tracks in Asymptomatic Alzheimer’s Patients
Published: Apr 28, 2026
Section: Research
Researchers from the Keck School of Medicine of USC have identified that preclinical Alzheimer’s disease progresses through stable, slow, and fast cognitive trajectories rather tha...
- USC Study Identifies Three Unique Cognitive Trajectories in Preclinical Alzheimer’s Disease to Improve Clinical Trial Accuracy
Published: Apr 28, 2026
Section: Medical News
Researchers at the Keck School of Medicine of USC have identified three distinct patterns of cognitive progression in preclinical Alzheimer’s patients: stable, slow decline, and fa...
- UT Health San Antonio Secures Grant to Investigate Link Between Chronic Jet Lag and Alzheimer’s Risk
Published: Apr 28, 2026
Section: Research
Researchers at UT Health San Antonio have received a $200,000 Alzheimer’s Association grant to study how environmental stressors, including sleep disruption and high-fat diets, inf...
- Scripps Research Scientists Identify Molecular Switch Driving Chronic Brain Inflammation in Alzheimer’s Patients
Published: Apr 25, 2026
Section: Medical News
Researchers have discovered that the chemical modification of the STING protein, known as S-nitrosylation, triggers a cycle of damaging overactivation in the brain's immune cells....
- Netherlands Institute for Neuroscience Identifies Cellular Survival Programs Driving Cognitive Resilience Against Alzheimer’s Disease
Published: Apr 25, 2026
Section: Medical News
Researchers have discovered that cognitive resilience in Alzheimer’s disease is determined by the behavior of immature neurons rather than their quantity. A study of brain tissue f...
- Scripps Research Scientists Discover Molecular STING Switch Driving Chronic Neuroinflammation in Alzheimer’s Disease Patients
Published: Apr 25, 2026
Section: Medical News
Researchers at Scripps Research have identified a chemical modification of the STING protein, known as S-nitrosylation, that triggers harmful brain inflammation in Alzheimer’s dise...
- Boston Children's Researchers Find "Cancer-Like" Mutations in Brain Immune Cells May Be a Primary Driver of Alzheimer's
Published: Apr 22, 2026
Section: Health Technology
A groundbreaking study published in Cell suggests that Alzheimer’s disease may be driven by the same genetic mutations that cause blood cancers. Researchers at Boston Children’s Ho...
- NYU Langone Study Links Elevated White Blood Cell Ratios to Early Alzheimer’s and Dementia Risks
Published: Apr 21, 2026
Section: Medical News
Researchers at NYU Langone Health have identified that a high ratio of neutrophils to lymphocytes can predict dementia risk before cognitive symptoms appear. Analyzing data from ne...
- Johns Hopkins Research Reveals Brain Organoids Can Predict Patient-Specific Alzheimer’s Drug Responses
Published: Apr 21, 2026
Section: Medical News
Scientists at Johns Hopkins Medicine have demonstrated that lab-grown brain organoids can be used to identify which Alzheimer’s patients will respond to common psychiatric treatmen...
- AlzeCure Pharma Completes Final Patient Visits in Phase Ib Clinical Trial for Alzheimer’s Candidate ACD856
Published: Apr 21, 2026
Section: Health
AlzeCure Pharma AB has reached a major milestone with the conclusion of the last patient’s last visit in its Phase Ib clinical study of ACD856, a first in class NeuroRestore platfo...